Myasthenia Gravis Treatment Market Size, Share, and Growth Forecast, 2025 - 2032

Table of Content

1. Executive Summary
   1. Global Myasthenia Gravis Treatment Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 – 2032, US$ Bn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
   3. Macro-economic Factors
      1. Global Sectoral Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors – Relevance and Impact
3. Value Added Insights
   1. Tool Adoption Analysis
   2. Regulatory Landscape
   3. Value Chain Analysis
   4. PESTLE Analysis
   5. Porter’s Five Force Analysis
4. Price Analysis, 2024A
   1. Key Highlights
   2. Key Factors Impacting Deployment Costs
   3. Pricing Analysis, By Disease Type
5. Global Myasthenia Gravis Treatment Market Outlook
   1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
   2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Current Market Size (US$ Bn) Analysis and Forecast, 2025 – 2032
   3. Global Myasthenia Gravis Treatment Market Outlook: Drug Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Drug Class, 2019 – 2024
      3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 – 2032
         1. Immunosuppressants
         2. Monoclonal Antibodies
         3. Cholinesterase Inhibitors
         4. Corticosteroids
      4. Market Attractiveness Analysis: Drug Class
   4. Global Myasthenia Gravis Treatment Market Outlook: Disease Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Disease Type, 2019 – 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025 – 2032
         1. Generalized Myasthenia Gravis
         2. Ocular Myasthenia Gravis
      4. Market Attractiveness Analysis: Disease Type
   5. Global Myasthenia Gravis Treatment Market Outlook: End-User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End-User, 2019 – 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2025 – 2032
         1. Hospital
         2. Online Pharmacies
         3. Specialty Clinics
      4. Market Attractiveness Analysis: End-User
6. Global Myasthenia Gravis Treatment Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 – 2024
   3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025 – 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
7. North America Myasthenia Gravis Treatment Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2024
      1. By Country
      2. By Drug Class
      3. By Disease Type
      4. By End-User
   3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
      1. U.S.
      2. Canada
   4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 – 2032
      1. Immunosuppressants
      2. Monoclonal Antibodies
      3. Cholinesterase Inhibitors
      4. Corticosteroids
   5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025 – 2032
      1. Generalized Myasthenia Gravis
      2. Ocular Myasthenia Gravis
   6. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2025-2032
      1. Hospital
      2. Online Pharmacies
      3. Specialty Clinics
   7. Market Attractiveness Analysis
8. Europe Myasthenia Gravis Treatment Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2024
      1. By Country
      2. By Drug Class
      3. By Disease Type
      4. End-User
   3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 – 2032
      1. Immunosuppressants
      2. Monoclonal Antibodies
      3. Cholinesterase Inhibitors
      4. Corticosteroids
   5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025 – 2032
      1. Generalized Myasthenia Gravis
      2. Ocular Myasthenia Gravis
   6. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2025-2032
      1. Hospital
      2. Online Pharmacies
      3. Specialty Clinics
   7. Market Attractiveness Analysis
9. East Asia Myasthenia Gravis Treatment Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2024
      1. By Country
      2. By Drug Class
      3. By Disease Type
      4. By End-User
   3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
      1. China
      2. Japan
      3. South Korea
   4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 – 2032
      1. Immunosuppressants
      2. Monoclonal Antibodies
      3. Cholinesterase Inhibitors
      4. Corticosteroids
   5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025 – 2032
      1. Generalized Myasthenia Gravis
      2. Ocular Myasthenia Gravis
   6. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2025-2032
      1. Hospital
      2. Online Pharmacies
      3. Specialty Clinics
   7. Market Attractiveness Analysis
10. South Asia & Oceania Myasthenia Gravis Treatment Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2024
       1. By Country
       2. By Drug Class
       3. By Disease Type
       4. By End-User
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
       1. India
       2. Southeast Asia
       3. ANZ
       4. Rest of South Asia & Oceania
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 – 2032
       1. Immunosuppressants
       2. Monoclonal Antibodies
       3. Cholinesterase Inhibitors
       4. Corticosteroids
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025 – 2032
       1. Generalized Myasthenia Gravis
       2. Ocular Myasthenia Gravis
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2025-2032
       1. Hospital
       2. Online Pharmacies
       3. Specialty Clinics
    7. Market Attractiveness Analysis
11. Latin America Myasthenia Gravis Treatment Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2024
       1. By Country
       2. By Drug Class
       3. By Disease Type
       4. By End-User
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 – 2032
       1. Immunosuppressants
       2. Monoclonal Antibodies
       3. Cholinesterase Inhibitors
       4. Corticosteroids
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025 – 2032
       1. Generalized Myasthenia Gravis
       2. Ocular Myasthenia Gravis
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2025-2032
       1. Hospital
       2. Online Pharmacies
       3. Specialty Clinics
    7. Market Attractiveness Analysis
12. Middle East & Africa Myasthenia Gravis Treatment Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2024
       1. By Country
       2. By Drug Class
       3. By Disease Type
       4. By End-User
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 – 2032
       1. Immunosuppressants
       2. Monoclonal Antibodies
       3. Cholinesterase Inhibitors
       4. Corticosteroids
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025 – 2032
       1. Generalized Myasthenia Gravis
       2. Ocular Myasthenia Gravis
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2025-2032
       1. Hospital
       2. Online Pharmacies
       3. Specialty Clinics
    7. Market Attractiveness Analysis
13. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
       1. Alexion Pharmaceutical Inc.
          1. Overview
          2. Segments and Deployments
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Grifols SA
       3. Avadel Pharmaceutical
       4. Novartis
       5. Pfizer Inc
       6. AbbVie Inc
       7. F Hoffmann-La Roche AG
       8. GlaxoSmithKline Plc
       9. Bausch Health Companies Inc
       10. Shire Plc
14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations